Today’s Top Three in Pharma 012809 posted on January 28, 2009Astellas makes a big to acquire CV Therapeutics. Japan's Astellas Pharma is offering a billion dollars in cash for CV Therapeutics. The bid comes in at $16 a share, a whopping 41 percent premium over …Continue Reading about Today’s Top Three in Pharma 012809 →